UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 3 |
Visa
V
|
+$141M |
| 4 |
Alibaba
BABA
|
+$137M |
| 5 |
Freeport-McMoran
FCX
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$196M |
| 2 |
Infosys
INFY
|
+$163M |
| 3 |
Monster Beverage
MNST
|
+$144M |
| 4 |
Mastercard
MA
|
+$128M |
| 5 |
Procter & Gamble
PG
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14.28% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Kinross Gold
KGC
$30.5B
| $15.9M | 0.02% |
4,776,034
+660,463
| +16% | +$2.59M |
|
702
Baytex Energy
BTE
$2.91B
| $15.8M | 0.02% |
416,608
+143,425
| +53% | +$6.1M |
|
703
ResMed
RMD
$32.5B
| $15.6M | 0.02% |
317,450
-39,035
| -11% | -$1.99M |
|
704
Douglas Emmett
DEI
$1.98B
| $15.6M | 0.02% |
608,539
+126,200
| +26% | +$3.55M |
|
|
HCBK
705
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $15.6M | 0.02% |
1,606,649
+43,585
| +3% | +$429K |
|
|
PFPT
706
DELISTED
Proofpoint, Inc.
PFPT
| $15.6M | 0.02% |
420,266
+2,270
| +0.5% | +$84.7K |
|
707
iShares MSCI Canada ETF
EWC
$6.28B
| $15.5M | 0.02% |
505,349
+123,671
| +32% | +$3.98M |
|
708
Crown Holdings
CCK
$13.3B
| $15.5M | 0.02% |
348,138
-4,293
| -1% | -$207K |
|
709
Ulta Beauty
ULTA
$23.2B
| $15.4M | 0.02% |
130,640
-7,151
| -5% | -$711K |
|
|
PDCO
710
DELISTED
Patterson Companies, Inc.
PDCO
| $15.2M | 0.02% |
367,912
+4,217
| +1% | +$168K |
|
|
CLR
711
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $15.2M | 0.02% |
228,682
+244
| +0.1% | +$18.2K |
|
712
Jazz Pharmaceuticals
JAZZ
$16.4B
| $15.1M | 0.02% |
94,105
+43,907
| +87% | +$6.75M |
|
|
AEGR
713
DELISTED
Aegerion Pharmaceuticals
AEGR
| $15M | 0.01% |
449,577
+20,214
| +5% | +$627K |
|
|
CBD
714
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $14.9M | 0.01% |
342,000
+21,900
| +7% | +$1.05M |
|
715
Mettler-Toledo International
MTD
$28.5B
| $14.8M | 0.01% |
57,887
+490
| +0.9% | +$129K |
|
716
Raymond James Financial
RJF
$34.7B
| $14.7M | 0.01% |
412,371
+897
| +0.2% | +$31.4K |
|
717
Santander
BSBR
$43.3B
| $14.7M | 0.01% |
2,347,205
+1,473,355
| +169% | +$9.6M |
|
718
Neurocrine Biosciences
NBIX
$16.4B
| $14.6M | 0.01% |
929,398
+39,500
| +4% | +$590K |
|
719
Wolfspeed
WOLF
$1.31B
| $14.5M | 0.01% |
353,816
+8,532
| +2% | +$394K |
|
|
HOLX
720
DELISTED
Hologic
HOLX
| $14.5M | 0.01% |
594,092
-16,092
| -3% | -$406K |
|
|
CBI
721
DELISTED
Chicago Bridge & Iron Nv
CBI
| $14.4M | 0.01% |
249,631
+2,034
| +0.8% | +$128K |
|
722
CubeSmart
CUBE
$9.52B
| $14.4M | 0.01% |
801,998
+35,441
| +5% | +$655K |
|
723
American Financial Group
AFG
$12.2B
| $14.4M | 0.01% |
248,047
-3,089
| -1% | -$181K |
|
724
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
| $14.1M | 0.01% |
306,866
+53,550
| +21% | +$2.68M |
|
|
S
725
DELISTED
Sprint Corporation
S
| $14.1M | 0.01% |
2,226,240
-98,531
| -4% | -$671K |
|
Similar funds
UBS AM's Q3 2014 Portfolio in Review
As of Q3 2014, UBS AM held 2,623 positions worth $101B, up 1.8% from $99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q3 2014 filing shows 68 new, 1,056 increased, 515 reduced and 65 closed positions. Its largest new stake was Alibaba: 1,521,250 shares worth $135M. The largest sale was Kellanova, an estimated $196M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q3 2014 buy was Alibaba: 1,521,250 shares worth $135M.
- UBS AM added most to Apple in Q3 2014, an estimated $204M increase.
- UBS AM's biggest Q3 2014 reduction was Kellanova, cutting an estimated $196M.
- UBS AM fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $80.9M.
- UBS AM's ten largest holdings make up 15% of its $101B portfolio in Q3 2014.
- UBS AM opened 68 new positions and closed 65 in Q3 2014.
- UBS AM's portfolio value rose 1.8% quarter-over-quarter to $101B.
Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.